Samil Pharm is a South Korean pharmaceutical company that offers CDMO (Contract Development and Manufacturing Organization) services, R&D, and products.  Samil Pharm's self-described goal is to achieve Human Care through its products.

삼일제약

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.

0005

COM:SAMIL-PHARM

삼일제약

Last Close

15,900.00

25/09 06:30

Market Cap

169.82B

Beta: -

Volume Today

694.45K

Avg: -

Analysis Not Available